For the year ending 2025-12-27, CRL has $7,135,422K in assets. $3,924,228K in debts. $213,770K in cash and cash equivalents.
| Balance Sheets | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 213,770 | 194,606 | 276,771 | 233,912 |
| Trade receivables and contract assets, net of allowances for credit losses of 10,463 and 18,301, respectively | 708,856 | 720,915 | 780,375 | 752,390 |
| Inventories | 299,103 | 278,544 | 380,259 | 255,809 |
| Prepaid assets | 96,108 | 103,210 | 87,879 | 89,341 |
| Other current assets | 129,212 | 105,796 | 83,378 | 107,580 |
| Total current assets | 1,447,049 | 1,403,071 | 1,608,662 | 1,439,032 |
| Property, plant and equipment, net | 1,655,219 | 1,604,014 | 1,639,741 | 1,465,655 |
| Venture capital and strategic equity investments | 206,972 | 218,350 | 243,811 | 311,602 |
| Operating lease right-of-use assets, net | 361,415 | 412,490 | 394,029 | 391,762 |
| Goodwill | 2,764,253 | 2,846,608 | 3,095,045 | 2,849,903 |
| Intangible assets, net | 339,995 | 723,400 | 864,051 | 955,275 |
| Deferred tax assets | 67,334 | 42,179 | 40,279 | 41,262 |
| Other assets | 293,185 | 278,233 | 309,383 | 148,279 |
| Total assets | 7,135,422 | 7,528,345 | 8,195,001 | 7,602,770 |
| Accounts payable | 148,800 | 140,337 | 168,937 | 205,915 |
| Accrued compensation | 268,854 | 179,418 | 213,290 | 197,078 |
| Deferred revenue | 210,418 | 248,322 | 241,820 | 264,259 |
| Accrued liabilities | 270,085 | 232,010 | 227,825 | 219,758 |
| Other current liabilities | 222,158 | 194,014 | 203,210 | 204,575 |
| Total current liabilities | 1,120,315 | 994,101 | 1,055,082 | 1,091,585 |
| Long-term debt, net and finance leases | 2,136,360 | 2,240,205 | 2,647,147 | 2,707,531 |
| Operating lease right-of-use liabilities | 434,048 | 483,789 | 419,234 | 389,745 |
| Deferred tax liabilities | 95,203 | 106,960 | 191,349 | 215,582 |
| Other long-term liabilities | 138,302 | 195,212 | 223,191 | 174,822 |
| Total liabilities | 3,924,228 | 4,020,267 | 4,536,003 | 4,579,265 |
| Redeemable noncontrolling interests | 41,263 | 41,126 | 56,722 | 42,427 |
| Common stock, 0.01 par value 120,000 shares authorized 49,217 shares issued and outstanding as of december27, 2025 and 51,141 shares issued and outstanding as of december28, 2024 | 492 | 511 | 513 | 509 |
| Additional paid-in capital | 1,947,301 | 1,966,237 | 1,905,578 | 1,804,940 |
| Retained earnings | 1,388,620 | 1,812,100 | 1,887,218 | 1,432,901 |
| Treasury stock, at cost, zero shares as of december27, 2025 and december28, 2024 | 0 | 0 | 0 | 0 |
| Accumulated other comprehensive loss | -171,783 | -317,345 | -196,427 | -262,057 |
| Total charles river laboratories international, inc. equity | 3,164,630 | 3,461,503 | 3,596,882 | 2,976,293 |
| Nonredeemable noncontrolling interest | 5,301 | 5,449 | 5,394 | 4,785 |
| Total equity | 3,169,931 | 3,466,952 | 3,602,276 | 2,981,078 |
| Total liabilities, redeemable noncontrolling interests and equity | 7,135,422 | 7,528,345 | 8,195,001 | 7,602,770 |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)